FilingSEC EDGAR6-K
Quantum BioPharma's Licensee Unbuzzd Appoints New CEO and Targets Public Listing
· SEC accepted
StagePreparation
Filing content
Quantum BioPharma's licensee, Unbuzzd Wellness, has appointed Michael Zapolin as CEO and is preparing for a public listing and U.S. product rollout in the coming quarter.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…